Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: principles (564), values (295)

Institutional information_2024-25

Description: Institutional information – key facts for inclusion as appropriate Support statements must be personal to your application to avoid the same document being
Url: /Media/Southampton-Clinical-Research/Grants/Download/Institutional-information-2024-25.pdf

NIHR RTB_IBHO_PIS-ICF_v1.4_12SEP2024_Localised

Description: PARTICIPANT INFORMATION SHEET Improving Black Health Outcomes (IBHO) NIHR BioResource Version 1.4, 12 Sep 2024 Reading time:
Url: /Media/Southampton-Clinical-Research/Downloads/NIHR-RTB-IBHO-PIS-ICF-v1.4-12SEP2024-Localised.pdf

Papers CoG 23.10.2024

Description: Date Time Location Chair Agenda Council of Governors 23/10/2024 14:35 - 16:15 Conference Room, Heartbeat/Microsoft Teams Jenni
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Governors/Papers-CoG-23.10.2024.pdf

Azacitidine(SC)-Venetoclax

Description: Chemotherapy Protocol Acute Myeloid Leukaemia AZACITIDINE (SC) - VENETOCLAX Regimen  AML – Azacitidine (SC) - Venetoclax Indication  Newly diagnosed acute myeloid leukaemia (AML).  Patient
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AzacitidineSC-Venetoclax.pdf

DVdSC (weekly cycles1-8) Bortezomib-Daratumumab-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly cycles 1-8) Bortezomib-Daratumumab-Dexamethasone Regimen • Myeloma – DVd SC (weekly cycles 1-8) bortezomib
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles1-8-Bortezomib-Daratumumab-Dexamethasone-Ver1.pdf

Current funding calls

Description: Auto Generated Title Here you can find new grant funding calls from various funders. Links on the right will take you
Url: /ClinicalResearchinSouthampton/For-researchers/Grant-funding-support/Current-funding-calls/Current-funding-calls.aspx

Engaging for increased research participation - full report

Description: Engaging for increased research participation Public and healthcare professionals' perceptions For further information contact: Chris Stock Head of R&D communications
Url: /Media/Southampton-Clinical-Research/Marketresearch/Engaging-for-increased-research-participation-full-report-v2.pdf

421 to 427 of 427

Previous … 39 40 41 42 43 Next